Table 3.
The ANCOVA results testing for differences in the levels of complement cascade components after co-varying for potential confounding factors.
BD | Chlorpromazine equivalent | Valproate/valproic acid | Lamotrigine | BMI | Smoking | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
F | p | F | p | F | p | F | p | F | p | F | p | |
C3a | 30.032 | 0.000 | 0.000 | 0.993 | 0.000 | 0.990 | 0.014 | 0.907 | 0.054 | 0.817 | 0.043 | 0.837 |
C5a | 11.112 | 0.002 | 1.704 | 0.199 | 0.031 | 0.861 | 3.306 | 0.076 | 0.838 | 0.365 | 1.440 | 0.237 |
sqrtC5b9 | 4.022 | 0.051 | 0.117 | 0.734 | 0.021 | 0.885 | 0.036 | 0.850 | 0.001 | 0.975 | 0.030 | 0.864 |